significant preoperative differences between individuals developing liver dysfunction (LD) and controls, and multivariate logistic regression analysis revealed that two miRNA ratios were independently associated with LD after curative resection (all P < 0.01). Therefore, the author concluded that the novel miRNA-based biomarker represents a promising prognostic factor in patients undergoing partial hepatectomy, which might be helpful in guiding surgical decisions to the specific risk profile of patients. However, we would like to raise the following points:
As the authors mention, patients with and without LD were matched based on basic characteristics and liver function. However, showed in their study, albumin levels differed significantly between the two groups (39.1 [31.5-47.3] vs. 43.2 [37.0-46.6 ] g/dL; P = 0.004), suggesting that there was an unbalanced background for comparisons between the two groups. Albumin is one of the main factors in Child-Pugh classification, and it is an important marker of synthetic function. Decreases in serum albumin concentrations lead to increased perioperative morbidity and mortality rates.
(2) Therefore, we highly recommend that albumin should be matched between the two groups.
In addition, the number of variables on patients' baseline characteristics in this study seemed insufficient (e.g., operative time, operative estimated blood loss, (3) need for vena cava or other vascular resection, (4) and blood transfusion requirement (5) ), even though these variables have an important influence on the postoperative morbidity and mortality, as demonstrated in many studies.
(3-5) Therefore, the reliability and accuracy of the conclusions of this study need further evaluation.
Furthermore, whether analyzing miRNA would cost more money and cause longer wait times or even delay treatment is another important aspect that must be considered in translational medicine.
In conclusion, we deeply appreciate the authors' work. Moreover, we suggest that the level of albumin in preoperative groups should be matched. In addition, more details on the variables of patients' characteristics should be included in this study. Clarification about the omissions we mention would greatly solidify the conclusions of the study by Starlinger et al. 
REPLY:
We thank Dai et al. for their interest in our study. Indeed, plasma albumin levels significantly differed between patients with and without liver dysfunction (LD) in our exploration cohort.
(1) As mentioned by the authors, it is already known that decreased plasma albumin levels correlate with perioperative outcome. However, we feel quite confident about our results, as we were able to validate the predictive potential of our microRNA (miRNA) signature in an independent validation cohort in whom no significant differences in albumin levels were observed. Of note, the differences in the exploration cohort depend on 4 patients with very low albumin levels. After excluding these 4 patients (allowing for comparable albumin levels 
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in both groups), we observed similar results as in our entire exploration cohort, indicating that albumin levels do not appear to account for the predictive potential of miRNAs (Fig. 1) .
As the aim of our study was to define the potential of a preoperative plasma miRNA signature to predict surgical outcome, we strongly disagree to include intraoperative characteristics in our analyses. It is simply not valid to stratify for intraoperative characteristics when we aim to use markers to predict liver dysfunction prior to resection. Furthermore, the identified combination of miRNAs appears to identify patients at high risk for postoperative complications with very high sensitivity. Obviously, high-risk patients have the highest intraoperative blood loss, the longest operative time, and the need for Pringle maneuver and blood transfusion. Consequently, if we were to stratify for these intraoperative variables, we would stratify for patients whom we would ultimately like to identify with our preoperative marker, and this certainly would not make sense. Therefore, we acknowledge the authors comments, but disagree with the statement that "the reliability and accuracy of the conclusions of this study need further evaluation," at least not by including intraoperative variables.
Indeed, we are in the process of further validating the reliability, accuracy, and cost-effectiveness of our FIg. 1. Exclusion of low-albumin patients confirms the predictive potential of miRNAs for postoperative liver dysfunction. Four patients with very low albumin were excluded from the analyses to achieve increased homogeneity in the exploration cohort. None of the evaluated liver function parameters were significantly different within the patients with and without LD after exclusion of these 4 patients. (A) Receiver operating characteristic analysis for the combined miRNA ratios with respect to LD. (B,C) Incidence of postoperative LD in patients stratified to our cutoffs of greater than 0.59 and greater than 0.68, respectively. Abbreviations: AUC, area under the curve; Ctrl, control; and Pred., predicted.
